Richard Justice
Financieel Directeur/CFO bij Mie Pay Ltd.
Profiel
Richard Justice is currently the Chief Financial Officer at Mie Pay Ltd.
He previously worked as a Secretary at New Talisman Gold Mines Ltd., and as the Chief Financial Officer at Algorae Pharmaceuticals Ltd.
and Photonz Corp.
Ltd.
Mr. Justice obtained an undergraduate degree and an MBA from Auckland University.
Actieve functies van Richard Justice
Bedrijven | Functie | Begin |
---|---|---|
Mie Pay Ltd.
Mie Pay Ltd. Packaged SoftwareTechnology Services Mie Pay Ltd. is a holding company, which engages in the provision of E-commerce and payments platform. The company was founded on November 1, 2018 and is headquartered in Sydney, Australia. | Financieel Directeur/CFO | 04-11-2019 |
Eerdere bekende functies van Richard Justice
Bedrijven | Functie | Einde |
---|---|---|
ALGORAE PHARMACEUTICALS LIMITED | Financieel Directeur/CFO | - |
NEW TALISMAN GOLD MINES LIMITED | Bedrijfssecretaris | - |
Photonz Corp. Ltd.
Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Financieel Directeur/CFO | - |
Opleiding van Richard Justice
Auckland University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
NEW TALISMAN GOLD MINES LIMITED | Non-Energy Minerals |
Technology Services |
Bedrijven in privébezit | 1 |
---|---|
Photonz Corp. Ltd.
Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Health Technology |